Polypharmacy Interactions Impacting Methacholine Challenge Testing for Asthma Assessment in Older People
The Senior Care Pharmacist · 01.01.2023 · 38 (1) · 29-40
DOI: 10.4140/tcp.n.2023.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Senior Care Pharmacist, erschienen am 01.01.2023. Verfasst von Demetra E Antimisiaris und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Health Management and Systems Sciences, Department of Neurology, University of Louisville, Louisville, Kentucky. Hauptthemen laut MEDLINE: Polypharmacy, Asthma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Objective
To investigate potential reasons for unusually high incidence of negative Methacholine Challenge Tests (MCT), following standardized MCT medication-hold protocol, in older people with physician-diagnosed asthma.
Design
An analysis of a longitudinal observational parent study of asthma.
Setting
Community-dwelling participants were evaluated in an outpatient clinic and at home.
Participants
Screening inclusion criteria for the parent study included 60 years of age or older, physician diagnosis of asthma, and a positive response to at least one of six asthma screening questions. Participants were enrolled in the study if they also demonstrate either: (1) a postbronchodilator administration response showing an increase of at least 12% and 200 mL in forced expiratory volume or an increase of at least 12% and 200 mL in forced vital capacity, or (2) an MCT result of PC20 ≤ 16 mg/mL (indicating bronchial hyper-responsiveness, MCT positive). Exclusion criteria included diagnosis of cognitive impairment or dementia, residing in a long-term care facility, more than 20 pack/ year smoking history or a history of smoking within the previous five years, inability to perform pulmonary function testing maneuvers, and a Prognostic Index score of greater than 10.
Interventions
Analysis of participant data for non-medication- and medication-exposure factors for association with negative MCT results.
Results
Anticholinergic burden and statin use were positively associated with negative MCT.
Conclusion
Medications not accounted for in medication-hold protocols, and concurrently in use, may impact clinical tests and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1 Department of Health Management and Systems Sciences, Department of Neurology, University of Louisville, Louisville, Kentucky.
- 3 Jerald B. Katz Academy, Houston Methodist Research Institute, Houston, Texas.
- 5 Department of Pulmonary and Critical Care Medicine, University of Louisville, Louisville, Kentucky.
- 7 University of Kansas School of Nursing, Kansas City, Kansas.
Förderung
- NIA NIH HHS
Zitieren
APA
Antimisiaris, D. E., Folz, R. J., Cavallazzi, R. S., & Polivka, B. J. (2023). Polypharmacy Interactions Impacting Methacholine Challenge Testing for Asthma Assessment in Older People. The Senior Care Pharmacist, 38(1), 29-40. https://doi.org/10.4140/tcp.n.2023.29
Vancouver
Antimisiaris DE, Folz RJ, Cavallazzi RS, Polivka BJ. Polypharmacy Interactions Impacting Methacholine Challenge Testing for Asthma Assessment in Older People. The Senior Care Pharmacist. 2023;38(1):29-40. doi:10.4140/tcp.n.2023.29
BibTeX
@article{Antimisiaris2023,
author = {Antimisiaris, Demetra E and Folz, Rodney J and Cavallazzi, Rodrigo S and Polivka, Barbara J},
title = {Polypharmacy Interactions Impacting Methacholine Challenge Testing for Asthma Assessment in Older People},
journal = {The Senior Care Pharmacist},
year = {2023},
volume = {38},
number = {1},
pages = {29--40},
doi = {10.4140/tcp.n.2023.29}
}
EUVIMED